Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Two Dividend Growth Stocks on My Radar

In the past few days, I have noticed that a couple of dividend growth stocks have been selling at lower prices than before. Those are companies that have managed to grow earnings, and dividends over time. These companies are usually overvalued, but recent weakness has brought them closer to fair value territory. I would be interested in each one of those companies on dips below 20 times earnings. The companies include:

VF Corp (NYSE:VFC) engages in the design, production, procurement, marketing, and distribution of branded lifestyle apparel, footwear, and related products in the United States and Europe.

This dividend champion has increased dividends for 43 years in a row. Over the past decade, it has managed to boost dividends at a rate of 17.10%/year.

excellent, business, asia, suit, up, man, outdoor, closeup, leader, guy, thumb, chinese, urban, sign, symbol, finger, male, kong, outside, occupation, east, satisfaction,


The company earned $2.85/share in 2015, and is expected to grow earnings to $3.20 in 2016 and $3.57 in 2017.

Currently, the stock is selling for 17.10 times expected earnings and yields 2.40%. Check my last analysis of V.F. Corporation for more information about the company.

Follow V F Corp (NYSE:VFC)
Trade (NYSE:VFC) Now!

Novo Nordisk A/S (ADR) (NYSE:NVO), a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. This company is based in Denmark, and as a result there will be fluctuations due to currency when earnings and dividends are translated into US dollars. For international dividend growth stocks, you want to look at the payment in local currency, not in US dollars when determining track record of annual dividend increases. Novo Nordisk is a leader in the diabetes market. Unfortunately, given the increasing number of overweight individuals eating unhealthy foods worldwide, diabetes is expected to spread in the future. This may work well for companies like Novo Nordisk A/S (ADR) (NYSE:NVO).

On the other hand, the stock has taken a beating, due to increased competition from other drug makers, the company reducing its near term growth forecast by a notch, and cutbacks affecting 2.5% of its global staff. Near term pressures on its drug pricing may also be raising fears that the future may not be as rosy as in the past.

The company earned $2.01/share in 2015, and is expected to grow earnings to $2.28 in 2016 and $2.43 in 2017.

Novo Nordisk A/S (ADR) (NYSE:NVO) is an international dividend achiever that has increased dividends every year since 1995. Over the past decade, it has managed to boost dividends by a factor of 10.

Currently, the stock is selling for 20.30 times earnings and yields 2.40%. I would be interested in initiating a small position on dips below $40/share. I may be even more interested in the company at lower prices.

As a side note, dividends paid by Danish companies to US investors are subject to a 27% withholding tax at the source. There is a lengthy process for US investors to reclaim some of the excess withheld, which is described here. If you decide to invest in Novo Nordisk, it makes sense to do so in a taxable account.

As usual, I am interested in building out positions in those companies slowly. This would insulate me in case stock prices fall further from here. I would try to post a more detailed analysis of each company within the next few weeks.

Follow Novo Nordisk A S (NYSE:NVO)
Trade (NYSE:NVO) Now!

Full Disclosure: Long VFC

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.